List view / Grid view
HIV research using human primary cells: despite intense research in the 30 years since the discovery of HIV/AIDS, the disease remains a global epidemic with no credible vaccine available.
This whitepaper offers a detailed analysis of the differences between AccuGENX-ID™ and the MicroSEQ® v2.0* methodologies in obtaining an accurate identification.
Download this free white paper for detailed insight into the advantages of autoantibodies as biomarkers, including a review of the current technology and best practices for identification of sensitive and specific autoantibody biomarkers.
Dr John Rossi is Chair and Professor of the Department of Molecular and Cellular Biology at the Beckman Research Institute of City of Hope (Duarte, CA). His research focuses on the biology and applications of eukaryotic small RNAs and, in particular, their therapeutic use in HIV/AIDS and cancer.
RNA-Seq is a powerful sequencing-based method that enables researchers to discover, profile, and quantify RNA transcripts across the entire transcriptome.
Profiling of putative lead compounds against a representative panel of important enzymes, receptors, ion channels and transporters is an excellent way to establish a preliminary view of potential issues that might later hamper development.
